Status:
SUSPENDED
Montelukast for Prevention & Treatment of OHSS
Lead Sponsor:
Benha University
Collaborating Sponsors:
Hawaa Fertility Center
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
20-37 years
Phase:
PHASE2
Brief Summary
montelukast \& dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one group in comparison with dydrogesteron alone in the other group.
Detailed Description
patients with high risk for ovarian hyperstimulation will undergo a freeze-all protocol then montelukast \& dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one...
Eligibility Criteria
Inclusion
- PCOS high responders high numbers of ovum retrieved
Exclusion
- hypersensitivity to any drug components phenylketonuria patients depression liver dysfunction
Key Trial Info
Start Date :
December 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03794037
Start Date
December 5 2018
End Date
December 1 2023
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banha University- Hawaa Fertility center
Banhā, Qalyubia Governorate, Egypt, 13512